Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Digi Power X Inc.: Digi Power X Provides Operations and Financial Update (Accesswire) +++ DIGI POWER X Aktie +4,52%

MEIRAGTX Aktie

 >MEIRAGTX Aktienkurs 
12.35 EUR    (TradegateBSX)
Ask: 12.6 EUR / 402 Stück
Bid: 12.1 EUR / 500 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
MEIRAGTX Aktie über LYNX handeln
>MEIRAGTX Performance
1 Woche: +11,0%
1 Monat: +55,8%
3 Monate: +52,8%
6 Monate: +89,8%
1 Jahr: +92,1%
laufendes Jahr: +82,7%
>MEIRAGTX Aktie
Name:  MEIRAGTX HLDGSDL-,0000388
Land:  China
Sektor:  Gesundheit
ISIN/ Wkn:  KYG596651029 / A2JGHF
Symbol/ Ticker:  328 (Frankfurt) / MGTX (NASDAQ)
Kürzel:  FRA:328, ETR:328, 328:GR, NASDAQ:MGTX
Index:  -
Webseite:  https://meiragtx.com/
Profil:  MeiraGTx Holdings plc is a clinical-stage gene therapy company focused on developing novel treatments for serious diseases. The company's primary aim is to harness the transformative potential of gene therapy to address otherwise unmet medical needs...
>Volltext..
Marktkapitalisierung:  1127.07 Mio. EUR
Unternehmenswert:  1140.9 Mio. EUR
Umsatz:  69.73 Mio. EUR
EBITDA:  -82.29 Mio. EUR
Nettogewinn:  -105.38 Mio. EUR
Gewinn je Aktie:  -1.3 EUR
Schulden:  76.53 Mio. EUR
Liquide Mittel:  62.55 Mio. EUR
Operativer Cashflow:  7.24 Mio. EUR
Bargeldquote:  0.41
Umsatzwachstum:  116.42%
Gewinnwachstum:  32.55%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  MEIRAGTX
Letzte Datenerhebung:  07.07.26
>MEIRAGTX Kennzahlen
Aktien/ Unternehmen:
Aktien: 92.61 Mio. St.
Frei handelbar: 75.64%
Leerverk. Aktien: 5.99%
Rückkaufquote: -0.52%
Mitarbeiter: 403
Umsatz/Mitarb.: 0.18 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 144.64%
Bewertung:
KGV: -
KGV lG: -
KUV: 9.49
KBV: -
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: 79.77%
Gewinnmarge: -151.12%
Operative Marge: -133.64%
Managementeffizenz:
Gesamtkaprendite: -51.44%
Eigenkaprendite: -
>MEIRAGTX Peer Group
Gesundheit, Zell- & Gentherapie/ Gentechnik/ Erbkrankheiten, Neurologische Erkrankungen/ Schlaganfälle
 
07.07.26 - 14:09
 MeiraGTx wins $400M investment from Oberland Capital (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.07.26 - 13:33
 MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (bota-vec) (GlobeNewswire EN)
 
LONDON and NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced that it has entered into an agreement with Oberland Capital Management LLC (Oberland Capital) for an investment of up to $400 million in the Company, including up to $375 million in non-dilutive capital for capped royalty payments on certain products and up to $25 million in equity....
20.05.26 - 08:01
 Insiderhandel: PRESIDENT & CEO verkauft Aktien von MeiraGTx Holdings im Wert von 568540 USD (Insiderkauf)
 
Forbes, Alexandria - Vorstand - Tag der Transaktion: 2026-05-19...
14.05.26 - 22:33
 MeiraGTx Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN)
 
LONDON and NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced that the Compensation Committee of the Company's Board of Directors approved equity awards to Penny Fleck in connection with her employment with the Company as Chief Development Officer. The equity awards were granted as an inducement material to the new employee entering employment with MeiraGTx in accordance with Nasdaq Listing Rule 5635(c)(4)....
14.05.26 - 17:15
 MeiraGTx Holdings PLC (MGTX) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
 
MeiraGTx (MGTX) delivered earnings and revenue surprises of -32.56% and -81.10%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?...
14.05.26 - 14:09
 MeiraGTx GAAP EPS of -$0.57 misses by $0.18, revenue of $0.29M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
14.05.26 - 14:03
 MeiraGTx Reports First Quarter 2026 Financial and Operational Results (GlobeNewswire EN)
 
LONDON and NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced financial and operational results for the first quarter ended March 31, 2026, and provided a corporate update....
05.05.26 - 17:30
 Will MeiraGTx Holdings PLC (MGTX) Report Negative Q1 Earnings? What You Should Know (Zacks)
 
MeiraGTx (MGTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....
22.04.26 - 09:02
 Insiderhandel: CFO & COO verkauft Aktien von MeiraGTx Holdings im Wert von 572320 USD (Insiderkauf)
 
Giroux, Richard - Vorstand - Tag der Transaktion: 2026-04-21...
20.04.26 - 14:30
 MeiraGTx (MGTX) Soars 6.8%: Is Further Upside Left in the Stock? (Zacks)
 
MeiraGTx (MGTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road....
16.04.26 - 17:36
 MeiraGTx eyes $100M equity offering after gene therapy deal with J&J (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
16.04.26 - 13:51
 MeiraGTx Announces Pricing of $100 Million Offering of Ordinary Shares (GlobeNewswire EN)
 
LONDON and NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced the pricing of an underwritten offering of 11,111,111 of its ordinary shares at an offering price of $9.00 per share. Gross proceeds to MeiraGTx from the offering are expected to be approximately $100 million, before deducting underwriting discounts and commissions and offering expenses. All of the ordinary shares in the offering are being sold by MeiraGTx....
16.04.26 - 13:12
 MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP) (GlobeNewswire EN)
 
LONDON and NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced that it has entered into an asset purchase agreement with Johnson & Johnson* (J&J) to acquire all interests in bota-vec for the treatment of XLRP....
16.04.26 - 13:03
 MeiraGTx Announces Positive Three-year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Late Radiation-Induced Xerostomia (GlobeNewswire EN)
 
LONDON and NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced positive three-year data from the completed Phase 1 AQUAx study of AAV-hAQP1 for the treatment of grade 2/3 late radiation-induced xerostomia (RIX)....
14.04.26 - 20:33
 MeiraGTx rises on upcoming Phase 1 readout for gene therapy (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
08.04.26 - 07:01
 Insiderhandel: CHIEF DEV. OFFICER verkauft Aktien von MeiraGTx Holdings im Wert von 258907 USD (Insiderkauf)
 
Naylor, Stuart - Vorstand - Tag der Transaktion: 2026-04-07...
31.03.26 - 16:45
 Strength Seen in MeiraGTx (MGTX): Can Its 6.2% Jump Turn into More Strength? (Zacks)
 
MeiraGTx (MGTX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term....
26.03.26 - 15:45
 MeiraGTx Holdings PLC (MGTX) Q4 Earnings and Revenues Surpass Estimates (Zacks)
 
MeiraGTx (MGTX) delivered earnings and revenue surprises of +131.67% and +3,027.14%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?...
25.03.26 - 07:01
 Insiderhandel: PRESIDENT & CEO verkauft Aktien von MeiraGTx Holdings im Wert von 459420 USD (Insiderkauf)
 
Forbes, Alexandria - Vorstand - Tag der Transaktion: 2026-03-24...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Ubi lex, ibi poena - Wo ein Gesetz, da auch eine Strafandrohung. - Nomen Nescio
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!